U lrike von Baumbach is a German billionaire heiress and a member of the von Baumbach family, which, along with the related Boehringer family, owns the pharmaceutical giant Boehringer Ingelheim. The company, founded in 1885 by Albert Boehringer, is one of the world's largest and most successful privately held pharmaceutical companies. It has major businesses in human drugs, animal health, and biopharmaceutical contract manufacturing.

The extended founding family has maintained control of the company for generations, a structure that allows the firm to focus on long-term research and development. Ulrike von Baumbach, like the other family shareholders, is not involved in the operational management of the company. Her vast fortune is derived entirely from her inherited stake in the highly profitable and secretive family-owned global enterprise.